+91 9650760803 
Published: October 18, 2021 | Updated: July 20, 2026
Key Takeaways
- 01. Treatment approach:
The therapy uses adult stem cells—mainly mesenchymal stem cells from umbilical-cord tissue or bone marrow—to target chronic kidney disorders. - 02. Mechanism of effect:
The cells reduce inflammation in the kidney, stimulate regeneration of damaged tissue, and improve renal function rather than replacing entire organs. - 03. Evidence and outcomes:
Reports show improved kidney function and reduced dialysis need in some patients. However, large-scale, long-term clinical data are still limited. - 04. Cost and access in India:
Treatment in Delhi is more affordable than in many Western countries. Exact cost depends on patient condition, severity, and treatment protocol. - 05. Regulatory and caution notes:
The therapy remains experimental. Insurance coverage is unlikely, and outcomes differ between patients.
Overview
Chronic kidney disease (CKD) affects an estimated 10% of the global population and is among the leading causes of death worldwide, driven largely by rising rates of diabetes, hypertension, and lifestyle-related risk factors. Because kidney damage is often silent in its early stages, many patients are diagnosed only after significant function has already been lost — which is why understanding the disease’s causes, symptoms, and diagnostic pathway matters as much as understanding treatment options.
Kidney disease is not a single condition — it is the end result of several different underlying processes (diabetes, hypertension, chronic infection, autoimmune disease, or genetic conditions like polycystic kidney disease), and the right management approach depends on identifying which one applies to you. Investigational stem cell therapy is being studied specifically for chronic kidney disease and diabetic nephropathy, where the goal is to reduce inflammation and support renal tissue repair — not to reverse structural damage from causes like obstruction or advanced polycystic disease.
If you already have lab reports showing elevated creatinine or reduced eGFR, the Diagnosis section below explains what those numbers typically mean and what additional testing your nephrologist may recommend. If you’re evaluating whether stem cell therapy could be relevant to your specific case, start with Treatment and Our Promise, where we explain who is — and isn’t — a reasonable candidate.
For readers researching related conditions: see our Diabetes hub page if diabetic nephropathy is your underlying cause, our dedicated Diabetic Nephropathy page for a condition-specific deep dive, or the Organ-Specific hub for other organ-targeted therapies we offer.
What causes kidney disease?
Kidney disease develops when the kidneys’ filtering function is damaged over time (chronic) or suddenly (acute). The most common causes include:
- Diabetes — the leading cause of chronic kidney disease worldwide; consistently high blood sugar damages the kidneys’ filtering units over years. See our dedicated Diabetic Nephropathy page if this applies to you.
- High blood pressure (hypertension) — sustained pressure damages the small blood vessels within the kidneys.
- Chronic kidney infection or glomerulonephritis — repeated or unresolved infection/inflammation of kidney tissue.
- Polycystic kidney disease — a genetic condition causing fluid-filled cysts that progressively impair function.
- Heart disease — cardiovascular and kidney health are closely linked; poor heart function reduces blood flow to the kidneys over time.
Additional risk factors
- Long-term overuse of NSAIDs or certain antacids
- Exposure to environmental toxins (heavy metals, pesticides)
- Excessive alcohol consumption and smoking
- Family history of kidney disease
- Recurrent urinary tract or kidney infections
Why this distinction matters for treatment choice
Current stem cell research in nephrology has concentrated on chronic kidney disease and diabetic nephropathy, where inflammation and gradual tissue damage are the primary drivers — mechanisms that MSC-based approaches are specifically being studied to address (see Mechanism). It has not shown relevant application to kidney disease caused by structural obstruction, late-stage polycystic disease, or single-kidney anatomical issues, which typically require surgical or interventional management instead. If your case falls into this category, our specialist team will say so directly during your evaluation rather than propose an unsuitable protocol.
How to recognize the symptoms of kidney disease
Early kidney disease frequently causes no noticeable symptoms, which is why lab-confirmed diagnosis (see Diagnosis) matters more than symptom-watching alone. That said, the following signs are worth flagging to a doctor:
- Changes in urination — more frequent urination (especially at night), darker or foamy urine, or visible blood in urine.
- Pain or discomfort during urination.
- Swelling (edema) — particularly in the ankles, feet, legs, or around the eyes, caused by fluid retention.
- Persistent fatigue and weakness — related to reduced red blood cell production as kidney function declines.
- Loss of appetite, nausea, or a metallic taste — signs of waste buildup in the blood.
- Difficulty sleeping and muscle cramping, especially at night.
- Persistently high blood pressure that’s difficult to control.
What to do if you notice these signs
None of these symptoms should lead directly to a stem cell therapy consultation. The correct next step is a kidney function blood and urine panel — see Diagnosis — since the same symptom (say, swelling) can point to causes ranging from early CKD to heart-related fluid retention, which are managed very differently.
How is kidney disease diagnosed?
No stem cell protocol is proposed at Viezec without a completed nephrology work-up. This typically includes:
| Test | What it checks | Why it matters here |
|---|---|---|
| Serum creatinine & eGFR (blood test) | Kidney filtering function | Core marker used to stage CKD (Stage 1–5) and track progression |
| Urinalysis / urine albumin-to-creatinine ratio | Protein or blood leaking into urine | Early sign of kidney damage, often before creatinine rises |
| Renal ultrasound | Kidney size, structure, blockages, cysts | Rules in/out structural or obstructive causes not suited to stem cell approaches |
| Kidney biopsy (in select cases) | Tissue-level diagnosis | Used when the cause of kidney damage isn’t clear from blood/urine tests alone |
| HbA1c and blood pressure monitoring | Underlying diabetes/hypertension control | Confirms whether diabetic nephropathy or hypertensive nephropathy is the driving cause |
Your reports are reviewed by our specialist team before any protocol is proposed. If you already have recent reports (within the last 3–6 months), you can upload them for a free case review rather than repeating tests unnecessarily.
Note on interpreting your own results: eGFR staging alone doesn’t determine candidacy — the underlying cause, rate of decline, and whether structural damage is present are read together by a nephrologist and our specialist team. This is explained further under Who Is a Candidate in the Treatment section below.
Stem Cell Treatment for Kidney Disease in Delhi, India
Investigational stem cell therapy for kidney disease uses mesenchymal stem cells (MSCs) — typically sourced from bone marrow, umbilical cord tissue, or adipose tissue — to target chronic kidney disease and diabetic nephropathy specifically. It is delivered by our specialist team at Viezec’s accredited New Delhi facility as a supportive, complementary option alongside standard nephrology care — not a replacement for dialysis, transplant, or prescribed medication. Eligibility depends entirely on your specific diagnosis, confirmed beforehand — see Diagnosis.
How does it work?
Mesenchymal stem cells are being studied for mechanisms relevant to kidney disease specifically:
- Reducing renal inflammation — MSCs release anti-inflammatory signaling molecules that may help limit the inflammatory cascade driving progressive kidney damage.
- Supporting tissue repair — research suggests MSCs can differentiate into renal-supportive cell types and encourage local tissue-repair processes, rather than regenerating entire nephrons.
- Improving renal blood flow — some studies point to MSCs supporting new blood vessel formation, which may improve oxygen and nutrient delivery to stressed kidney tissue.
Cells are collected either from the patient herself (autologous, typically from bone marrow or fat tissue) or from screened donor tissue (allogeneic — most often umbilical cord), processed under lab conditions, and administered via one of several delivery routes depending on the protocol your specialist selects — see Implantation below.
Who is a candidate?
You may be considered a candidate if you have a confirmed diagnosis of:
- Chronic kidney disease (CKD), particularly earlier-to-moderate stages where some renal function remains
- Diabetic nephropathy — see our dedicated Diabetic Nephropathy page
- Select cases of acute kidney injury, evaluated individually
You are not likely to be a candidate if your kidney failure stems from late-stage structural disease, obstruction, or advanced polycystic kidney disease with minimal remaining function. These typically require dialysis or transplant pathways, and our specialist team will say so directly during your evaluation.
What to expect: the treatment process
- Consultation and diagnostic review — your existing reports (creatinine, eGFR, urinalysis, ultrasound) are reviewed by our specialist team.
- Cell sourcing — bone marrow or adipose tissue collection under local anaesthesia (autologous), or use of screened donor cord tissue (allogeneic).
- Lab processing — cells are isolated and prepared under controlled laboratory conditions, with a certificate of analysis issued for every batch.
- Administration — via intravenous, intra-arterial, or other route depending on your specific protocol (see Implantation).
- Follow-up monitoring — creatinine, eGFR, and urine markers are rechecked over the following weeks and months to assess response (see Improvements).
For international patients, see our visa and travel support and plan-your-visit resources.
Stem Cell Implantation Methods for Kidney Disease
The delivery route for stem cell therapy is selected based on your specific diagnosis, kidney function stage, and overall health — not applied uniformly to every patient. Common administration routes include:
- Intravenous administration — cells delivered through a vein, allowing systemic circulation; the most common route for CKD.
- Intra-arterial administration — cells delivered closer to the kidney’s blood supply for more targeted delivery in select cases.
- Intramuscular — used in select supportive protocols.
- Subcutaneous — used for certain supportive or combination protocols.
- Surgical/interventional administration — used only where imaging-guided or catheter-based delivery is clinically indicated.
The specific route, cell dose, and number of sessions are determined by your treating specialist after reviewing your diagnostic work-up — not a fixed protocol applied to every kidney patient.
Read more on our Stem Cell Delivery Methods page for a general explanation of how each route works across conditions.
Frequently Asked Questions
What is stem cell therapy for kidney disease?
Stem cell therapy for kidney disease involves using specialized stem cells to repair damaged kidney tissues, reduce inflammation, and potentially improve kidney function in patients with chronic or acute kidney conditions.
Who is eligible for stem cell therapy for kidney disease?
Candidates typically include patients with chronic kidney disease, diabetic nephropathy, or acute kidney injury. Eligibility is determined after thorough evaluation of medical history, lab tests, and overall health status.
How is stem cell therapy for kidney disease administered?
Stem cells are usually delivered intravenously or directly into the kidney through minimally invasive procedures. The method depends on the type of kidney disease and the patient’s overall condition.
Is stem cell therapy safe for kidney patients?
When performed in certified clinics with experienced medical teams, stem cell therapy is generally safe. Minor side effects may include mild fever, fatigue, or localized swelling at the injection site.
How long does it take to see improvements?
Improvements may be gradual and are typically observed over weeks to months. The timeline depends on disease severity, patient age, and individual response to the therapy.
How many sessions of stem cell therapy are required?
The number of sessions varies depending on patient needs and kidney condition. Most patients require 1–3 sessions, with follow-ups to monitor kidney function and overall progress.
Can stem cell therapy replace dialysis or medications?
Stem cell therapy is generally used as a complementary treatment alongside dialysis, medications, and lifestyle modifications. It is not a replacement for conventional treatments in most cases.
How can I schedule a consultation for stem cell therapy for kidney disease?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment request form on our website. Our specialists will evaluate your condition and provide a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Kidney Disease?
The cost of stem cell therapy for kidney disease depends on several factors including the underlying cause (such as chronic kidney disease, diabetic nephropathy, or glomerulonephritis), level of kidney damage, type of stem cells used, number of treatment sessions, and the medical center’s expertise. Treatment costs vary significantly across countries due to differences in healthcare standards and hospital charges. The following section provides a general cost comparison across leading medical destinations.
Cost Comparison: Select Countries
The table below outlines estimated cost ranges shared by clinics and patients for a complete stem cell therapy package — including consultation, stem cell preparation, infusion, and follow-up medical care.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $22,000 – $38,000 | ₹18,20,000 – ₹31,50,000 |
| United Kingdom 🇬🇧 | $16,000 – $26,000 | ₹13,20,000 – ₹21,50,000 |
| Germany 🇩🇪 | $19,000 – $29,000 | ₹15,80,000 – ₹24,10,000 |
| Singapore 🇸🇬 | $14,000 – $23,000 | ₹11,50,000 – ₹18,90,000 |
While countries like the USA, UK, and Germany offer advanced stem cell programs, they often come at higher prices due to medical infrastructure and administrative costs. In contrast, India provides comparable treatment quality at a significantly lower cost, making it one of the most sought-after destinations for affordable regenerative therapy for kidney conditions.
Lower treatment costs in India arise from operational efficiency, favorable currency rates, and streamlined healthcare systems. Importantly, many Indian centers utilize certified labs, advanced stem cell technologies, and internationally trained doctors — ensuring that affordability does not compromise quality.
Why Choose Viezec?
Viezec partners with accredited regenerative medicine centers that specialize in stem cell therapy for kidney disorders. Our focus is on ethical medical practice, transparent pricing, and delivering personalized patient care in line with global healthcare standards.
Get a Personalized Cost Estimate
Every patient’s health condition is unique. Reach out to our experts for a customized cost estimate and treatment plan tailored to your specific diagnosis and recovery goals.
Improvements Seen After Stem Cell Therapy for Kidney Disease
Current research and clinical observation on stem cell therapy for chronic kidney disease and diabetic nephropathy point to measurable changes in specific renal markers — not a guaranteed reversal of kidney failure. Results vary by CKD stage, underlying cause, and individual response.
What improvement typically looks like
- Balancing minerals and salts — improved regulation of electrolytes (sodium, potassium, phosphate) that the kidneys manage.
- Better-quality filtration — reflected in eGFR and creatinine trends over follow-up visits.
- Reduced disease progression — a slower rate of decline in kidney function compared to pre-treatment trajectory, rather than reversal to normal function.
- BUN and creatinine regularizing — movement toward more stable, better-controlled ranges in blood tests.
- Reduced inflammatory markers — consistent with the anti-inflammatory mechanism described under Mechanism.
How improvement is monitored, not just reported
At our Delhi facility, improvement is tracked through objective lab markers, not self-reported symptoms:
| Marker | What it shows | Typically checked at |
|---|---|---|
| Serum creatinine / eGFR | Kidney filtering trend | Baseline, 1, 3, 6 months |
| Urine albumin-to-creatinine ratio | Protein leakage / kidney damage | Baseline, 3 months |
| BUN (blood urea nitrogen) | Waste clearance | Baseline, 1, 3 months |
| Blood pressure | Cardiovascular-renal load | Ongoing |
| Dialysis frequency (if applicable) | Functional dependence on dialysis | Ongoing, per nephrologist |
What the research does not yet show
Most current evidence comes from small clinical trials, case series, and ongoing registered studies (see Scientific References) rather than large randomized controlled trials with long-term outcome data. Stem cell therapy is not established as a treatment that reverses kidney failure or eliminates the need for dialysis in advanced CKD. Your treating specialist will confirm, based on your specific lab trends, whether measurable improvement is a realistic goal in your case.
Mechanism of Action in Kidney Disease
Stem cell treatment for kidney disease primarily uses mesenchymal stem cells (MSCs), which carry growth factors and cytokines that support tissue repair and modulate the immune response. Within the kidney specifically, MSCs are being studied for their ability to:
- Differentiate into renal-supportive cell types — including renal epithelial cells, tubular cells, and functional mesangial cells, contributing to local tissue repair.
- Reduce inflammatory response against renal cells — helping to limit the ongoing inflammation that drives progressive kidney damage in CKD.
- Reduce apoptosis (cell death) — supporting the survival of stressed but still-viable kidney cells.
- Enhance renal function recovery — through combined anti-inflammatory and tissue-supportive paracrine signaling, rather than by regenerating an entire kidney.
This mechanism is why current research focuses on chronic, inflammation-driven kidney disease rather than structural or obstructive causes — the biological target (inflammation and cellular stress) is different from a mechanical blockage that stem cells cannot resolve.
Read the general mechanism explanation on our Physiological Mechanism page, which covers how MSCs act across multiple organ systems.
Our Promise
Viezec is committed to transparent, evidence-based regenerative medicine care for kidney disease — not overstated promises. In practice, this means:
- No cure claims. Stem cell therapy is offered as a researched, investigational, supportive option — never marketed as a guaranteed cure for kidney disease or a replacement for dialysis or transplant.
- Diagnosis before treatment. No stem cell protocol is proposed without a completed nephrology evaluation confirming candidacy — see Diagnosis.
- Named, credentialed medical oversight. Every treatment plan is reviewed by a qualified nephrology/regenerative medicine specialist.
- Regulatory transparency. Our protocols operate within India’s applicable regulatory framework for investigational stem cell use, and we disclose which framework applies to your specific treatment when asked, directly and in writing.
- Accredited facilities. Our treatment and cell-processing facilities hold NABH accreditation and NABL accreditation , verifiable through each body’s public registry.
- Written, itemized cost estimates. No flat public pricing, because cost genuinely varies by diagnosis and protocol, but a clear written estimate is provided after your medical evaluation, before you commit to anything.
- Location and access clarity. Our facility is based in New Delhi, India, with dedicated support for international patients including visa assistance, accommodation coordination, and post-treatment follow-up.
- Honest evidence communication. Where clinical evidence is still developing (as it is for stem cell therapy in kidney disease), we say so directly and cite the specific studies our approach is based on — see Scientific References — rather than implying stronger proof than currently exists.
In short: if a clinic won’t show you its accreditation numbers, name your treating physician, or give you a written cost estimate before treatment, that’s a signal to ask more questions. Independently verify the NABH registry, NABL registry, and Google Business listing linked below.
Treatment Results of Kidney Disease at Viezec
Stem cell therapy for kidney disease at Viezec (Delhi, India) has been used with patients diagnosed with chronic renal failure, including some who underwent autologous stem cell treatment following confirmed CKD diagnosis. Reported outcomes include improved quality of life and, in some cases, reduced frequency of or avoidance of hemodialysis. As with all findings on this page, individual results vary by disease stage, underlying cause, and overall health — this is not a guarantee of outcome for every patient.
What current published research shows
- A 2025 bibliometric and visualization analysis (Frontiers in Immunology) mapped a decade of global research trends in stem cell therapy for kidney disease, reflecting substantial and growing research interest in the field.
- A 2024 narrative review (Wang et al., Stem Cells International) examined mesenchymal stem cell mechanisms and clinical applications across renal diseases, noting both promising signals and the need for further controlled study.
- A 2025 Mayo Clinic study (Kidney International Reports) evaluated intra-arterial autologous mesenchymal stem cell therapy specifically in diabetic kidney disease patients.
- Ongoing registered trials, including a Mayo Clinic study on CKD and a Pakistan-based double-blind, placebo-controlled trial in diabetic kidney disease, continue to evaluate safety and effectiveness under controlled conditions.
What results can realistically be expected?
| Outcome measure | What research/clinical observation suggests |
|---|---|
| Creatinine / eGFR trend | Stabilization or improvement reported in some CKD/diabetic nephropathy patients |
| Dialysis frequency | Reduced frequency or delayed initiation reported in select cases |
| Inflammatory markers | Reduction reported in several small studies |
| Quality of life | Improvement reported by patients in clinical observation and case series |
| Full reversal of kidney failure | Not an established or guaranteed outcome, particularly in advanced-stage disease |
Watch patient video results for individual case examples — remember that testimonials reflect personal experiences and don’t represent guaranteed outcomes for every patient.
Testimonials
Rajesh M. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“Chronic kidney disease left me weak and tired. After Viezec’s stem cell therapy, my kidney function stabilized, and I feel stronger.”
Emma J. – London, UK – July 2020 – ⭐⭐⭐⭐⭐
“I was afraid of starting dialysis. Post-treatment at Viezec, my creatinine levels improved, and my condition feels under control.”
Ahmed S. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“My son had early kidney damage due to diabetes. After therapy at Viezec, his kidney function stabilized, and his energy returned.”
Isabella T. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“I had swelling and fatigue for years. Stem cell therapy at Viezec reduced my symptoms, and I feel much healthier now.”
George P. – Athens, Greece – September 2021 – ⭐⭐⭐⭐☆
“My kidney disease was progressing quickly. After treatment at Viezec, my reports improved, and I can live more actively.”
Hannah R. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“Kidney problems made daily life very hard. Viezec’s stem cell therapy gave me better kidney function and renewed energy.”
Omar H. – Amman, Jordan – August 2022 – ⭐⭐⭐⭐☆
“My father had chronic kidney disease. After Viezec’s therapy, his kidney health stabilized, and his weakness reduced.”
Maria G. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“Living with kidney disease was frightening. Stem cell therapy at Viezec helped restore my health and gave me hope.”
Daniel K. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“I struggled with high creatinine levels. After treatment at Viezec, my reports improved, and I feel active again.”
Fatima Z. – Istanbul, Turkey – May 2025 – ⭐⭐⭐⭐⭐
“Kidney disease had taken away my energy. Thanks to Viezec’s stem cell therapy, I feel healthier and free from constant fatigue.”
Kidney Disease Latest Blogs
How Effective Is Stem Cell Therapy In Liver Cirrhosis & Chronic Kidney Disease Patients?
Cirrhosis is a liver disease consequence characterised by the loss of liver cells and permanent scarring of the liver.
Kidney Cancer Symptoms, Diagnosis, And Treatment
Kidney cancer has direct links to an individual’s urine because the kidneys play a pivotal role in sieving waste products out of our blood. And like other types of cancer, kidney cancer might not instantaneously produce symptoms or if and when symptoms do surface, they might have done so for reasons except cancer.
What Is The Success Rate Of Kidney Transplant In India?
The chief function of kidneys is to filter the waste products from the body and transfigure them to urine. Kidney transplant is essential when there is a scenario of kidney failure. The failed or unhealthy kidney is then substituted with a healthy one. However, an appropriate donor needs to be found for the transplant.
All About Kidney Transplant Surgery and How is it Performed
How is transplant beneficial? Kidney transplantation is not an uncommon treatment these days and there are voluminous hospitals all over the country that have all the amenities and qualified doctors to perform this process efficaciously. Kidney transplant surgery in India can be defined as the transference of a healthy kidney from one individual to the body of an individual who has no or little kidney function.
Click Here For More Blogs
Treatment Disclaimer
Is stem cell therapy a guaranteed cure for kidney disease?
No. Stem cell therapy for kidney disease is experimental and may not work for every patient. At the time of evaluation, treatment may be declined, or the proposed protocol may change depending on your specific health condition. No guarantees or claims of cure are made regarding the extent of response to treatment.
What does the current evidence show?
Research into stem cell therapy for chronic kidney disease and diabetic nephropathy is still evolving. Some published studies and clinical observations report improved kidney function markers and reduced dialysis dependence in selected patients, while others show limited or inconsistent results. This is an active area of clinical research, not an established standard-of-care treatment recognized by major nephrology bodies at this time.
Who is this treatment intended for?
Only patients with a confirmed diagnosis of chronic kidney disease, diabetic nephropathy, or select cases of acute kidney injury, following a full nephrology work-up. It is not offered as a first-line treatment and is not appropriate for kidney failure caused by structural or obstructive disease.
What results can I realistically expect?
Individual results vary based on CKD stage, underlying cause, age, and overall health. Every patient has a different internal disease status, so results vary from patient to patient, even with a similar diagnosis. We do not publish blanket improvement percentages, because outcomes differ meaningfully between patients. We do not use embryonic or fetal cells in any of our treatments.
Who oversees treatment decisions?
All treatment plans are reviewed and overseen by our specialist team at our New Delhi facility, following evaluation of your creatinine/eGFR panel, urinalysis, and renal imaging. No protocol is recommended without this evaluation.
Is this treatment regulated?
Stem cell-based interventions beyond approved uses are considered investigational under Indian guidelines and are available only within regulated clinical research settings. We encourage every patient — in India or elsewhere — to ask directly which regulatory framework applies and to verify the facility’s accreditation before proceeding.
Where can I get a specific answer for my case?
Because kidney disease has many possible causes and stages, general information on this page cannot replace an individual medical evaluation. Book a consultation with our specialist team in New Delhi to review your reports and discuss candidacy.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Kidney Disease.
Conclusion
Stem cell therapy for kidney disease represents a promising advancement in regenerative medicine, offering the potential to repair damaged kidney tissues and restore vital renal function. At Viezec, we combine medical innovation, clinical expertise, and compassionate care to provide patients with safe and evidence-based treatment solutions. Our ethical approach and collaboration with leading hospitals in India ensure that every patient receives personalized attention and the highest standards of medical care. With India emerging as a hub for advanced stem cell therapies, Viezec helps patients access world-class options at affordable costs. To explore how stem cell treatment can improve kidney health and enhance quality of life, connect with our medical team today.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
